Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 30;23(6):43.
doi: 10.1007/s11926-021-01009-7.

Exogenous miRNA: A Perspective Role as Therapeutic in Rheumatoid Arthritis

Mohd Saquib  1   2 , Prachi Agnihotri  1 , Monu  1   2 , Sagarika Biswas  3
Affiliations
Review

Exogenous miRNA: A Perspective Role as Therapeutic in Rheumatoid Arthritis

Mohd Saquib et al. Curr Rheumatol Rep. .

Abstract

Rheumatoid arthritis (RA) is an autoimmune and chronic inflammatory disease that causes joint deformation. Till now several studies has been carried out promising its cure, but curing has not yet achieved to the satisfactory levels. Herbal approach to treat disease by a cross-kingdom mechanism via exogenous miRNA is an emerging trend to target associated genes with RA pathogenesis as a therapeutic potential. The concept of acquired/exogenous miRNA into pathophysiological prospect provides an opportunity to explore inter-species kingdom like regulation of plant miRNAs on human health. The change in gene expression was attributed by a short 22-24 nucleotide long sequence that binds to its complementary region to suppress/silence the gene expression. This makes exogenous miRNA a novel approach for targeted therapy to treat complex chronic inflammatory diseases. Here, aim of the review was to address significance of plant derived miRNA based targeted therapy to regulate inflammation in RA.

Keywords: Cross kingdom; Curcuma longa; Exogenous miRNA; Rheumatoid arthritis (RA); clo-mir-14; inflammation.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Pri. 2018;4:18001. This article describes the heterogeneity of RA disease.
    1. World Health Organization. Available from ttps:// www.who.int/chp/topics/rheumatic/en/ . Accessed 2019.
    1. Gierut A, Perlman H, Pope RM. Innate immunity and rheumatoid arthritis. Rheum Dis Clin. 2010;36(2):271–96. https://doi.org/10.1016/j.rdc.2010.03.004 . - DOI
    1. Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15. https://doi.org/10.1038/s41413-018-0016-9 . - DOI - PubMed - PMC
    1. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92–105. - DOI

Publication types

LinkOut - more resources